Trump administration officials and prominent business figures have voiced concerns about China's growing influence in key technology sectors affecting the United States.

Interior Secretary Doug Burgum characterized recent developments as "another attack on the US and our ability to be competitive," though specific details about data center-related issues were not immediately available. The comments came alongside broader discussions about maintaining American technological competitiveness.

Separately, China's biotechnology sector has drawn attention at international forums, including an oncology conference in Chicago where clinical trials conducted in China were prominently featured. The growing presence of Chinese biotech research has sparked discussions among industry observers about potential shifts in global pharmaceutical development.

The concerns reflect ongoing tensions between the US and China across multiple technology sectors, from data infrastructure to drug development. American officials and business leaders have increasingly focused on maintaining US leadership in areas considered critical to national and economic security.

These developments occur as both countries continue to compete for dominance in emerging technologies, with implications for everything from medical research to digital infrastructure.